trilab Competitors

LabWare is recognized as the global leader in providing enterprise-scale laboratory automation solutions with over 40 offices across six continents. LabWare’s Enterprise Laboratory Platform is a unique and proven suite of product capabilities that encompass LIMS, ELN, LES, method execution, SDMS, and advanced data analytics in an integrated and enterprise-ready solution. Our Enterprise Laboratory Platform combines the award-winning LabWare LIMS™ and LabWare ELN™. This comprehensive and fully integrated Electronic Laboratory Notebook application enables companies to optimize compliance, improve quality, increase productivity, and reduce costs. LabWare is a full-service provider offering software, professional implementation services, validation assistance, training, and world-class technical support to ensure our customers get the maximum value from their LabWare products. By paying close attention to customer needs, effectively using key technologies, and serving as a reliable and trusted partner, LabWare has emerged as the clear industry leader in laboratory automation.

In 2022, TECHLAB was acquired by SSI Diagnostica Group. Today, TECHLAB functions as a brand under SSI Diagnostica Group. About SSI Diagnostica Group: SSI Diagnostica Group is a global in vitro diagnostics (IVD) company, specializing in infectious disease diagnostics. We employ staff and operate offices in Denmark, the United States, and China, with a total of eleven sites across three different continents. Each year, we deliver diagnostic solutions in more than 130 countries and manufacture more than 60 million diagnostic tests – helping people receive the right diagnosis and, ultimately, the right treatment as quickly as possible. Operating as one company today, SSI Diagnostica Group is historically the result of a series of acquisitions: SSI Diagnostica (2016), CTK Biotech (2020), Beijing Genesee Biotech (2020), Techlab (2022), Gulf Coast Scientific (2025), and InDevR (2026). Each brand has brought unique expertise and experience to the group, and as a combined company we offer more than 200 years of combined scientific expertise. SSID Group’s mission is to empower healthcare professionals to prevent, monitor, and diagnose infectious diseases – enabling better treatment outcomes for patients worldwide. SSI Diagnostica group has four disease focus areas: Gastric, Respiratory, Bloodborne, and general microbiology.